News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Aliski William
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/01/2022 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Unknown transaction of 8,500 shares
@ $0
Disposed/sold 25,000 options to buy
@ $4.4, valued at
$110k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 12,000 options to buy
@ $4.72, valued at
$56.6k
|
|
| 08/25/2020 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 5,000 shares
@ $86.57, valued at
$432.9k
Exercised 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Aliski William (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 3,427 options to buy
@ $8.69, valued at
$29.8k
|
|
| 06/03/2020 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 20,000 shares
@ $74.0161, valued at
$1.5M
|
|
| 05/20/2020 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 7,500 shares
@ $74.65, valued at
$559.9k
Exercised 7,500 options to buy
@ $40.37, valued at
$302.8k
|
|
| 12/06/2019 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $3.02, valued at
$30.2k
|
|
| 09/20/2019 |
4
| Aliski William (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,854 options to buy
@ $14.04, valued at
$96.2k
|
|
| 06/13/2019 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
| 12/18/2018 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Bought 1,200 shares
@ $3.235, valued at
$3.9k
Bought 4,300 shares
@ $3.25, valued at
$14k
Bought 500 shares
@ $3.24, valued at
$1.6k
|
|
| 12/07/2018 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 6,000 shares
@ $49.69, valued at
$298.1k
|
|
| 11/19/2018 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $6.9, valued at
$69k
|
|
| 11/08/2018 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 6,000 shares
@ $55.67, valued at
$334k
|
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2018 |
4
| Aliski William (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 25,000 options to buy
@ $4.4, valued at
$110k
|
|
| 08/08/2018 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 3,750 shares
@ $76.66, valued at
$287.5k
|
|
| 06/20/2018 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $80.69, valued at
$403.5k
|
|
| 01/25/2018 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Exercised 11,500 options to buy
@ $21, valued at
$241.5k
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2016 |
4
| Aliski William (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,875 shares
@ $0
Granted 3,750 options to buy
@ $65.85, valued at
$246.9k
|
|
|
|